MedfusionRx, LLC is the leading independent specialty pharmacy provider in the Southeast and second in the United States. We are a licensed, accredited specialty pharmacy providing service in all 50 states.

MedfusionRx specializes in the needs of patients with chronic diseases such as bleeding disorders, growth hormone deficiency, multiple sclerosis, rheumatoid arthritis, plaque psoriasis, Crohn's disease and hepatitis C. We also specialize in medications for patients with cancer and in the preventive treatment of RSV.

98% of our customers indicate they would use MedfusionRx services again and would refer MedfusionRx to friends and family members. (Based on survey data 2010.)
MedfusionRx can reduce physician staff workloads and time spent coordinating specialty care for patients.
Refer your patients to MedfusionRx and let us work for you - if we are unable to provide service due to payer restrictions, we will coordinate services with an eligible provider for you.
96% patient compliance with prescribed treatment regimen (Based on 2009 data of patients on service for treatment of HCV)
"One characteristic that sets MedfusionRx apart from others in the industry is the ability to provide individualized service to physicians and patients." J. Herrera, MD
More for Physicians
MedfusionRx has specially trained staff to assist in the management of a variety of chronic diseases - customers are provided with a patient care coordinator to assist with needs associated with specialty drug therapy.
Insurance coverage for specialty pharmacy benefits can be complicated and often times, confusing for customers. Let our experienced staff assist you with benefit eligibility, prior authorization requirements, co-pay assistance and more.
"Staff was very professional & helpful. They were great about explaining everything thoroughly. It was great to talk with someone with exceptional customer service." V. Carr
More for Patients
MedfusionRx contracts with large pharmaceutical and biotech firms for distribution rights to certain medications. Participation in limited distribution networks are valuable in the fact they reduce fraud, increase patient compliance and improve overall therapeutic outcomes.
Collaborate with prescriber and insurance provider to ensure requirements, such as prior authorization, are met to manage the cost to patients and providers.
More for Health Plans/Payers